Rivernorth Capital Management’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Rivernorth Capital Management’s Portfolio DMAQR Stock Details DMAQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-150,000	Closed	-$45K	–	511
2023 Q4	$45K	Hold	150,000	–	–	﹤0.01%	262
2023 Q3	$52.5K	Hold	150,000	–	–	﹤0.01%	295
2023 Q2	$21K	Hold	150,000	–	–	﹤0.01%	365
2023 Q1	$22.5K	Hold	150,000	–	–	﹤0.01%	421
2022 Q4	$7.5K	Hold	150,000	–	–	﹤0.01%	574
2022 Q3	$6K	Hold	150,000	–	–	﹤0.01%	733
2022 Q2	$17K	Hold	150,000	–	–	﹤0.01%	608
2022 Q1	$27K	Hold	150,000	–	–	﹤0.01%	646
2021 Q4	$48K	Buy	+150,000	New	+$47.4K	﹤0.01%	565

Rivernorth Capital Management's DMAQR Position: Q1 2024 in Review

Rivernorth Capital Management sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 150,000 shares — an estimated $45K sold.

Rivernorth Capital Management first reported a position in DMAQR in Q4 2021 and held it in 9 quarters. The position peaked at $52.5K in Q3 2023. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

Rivernorth Capital Management reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
Rivernorth Capital Management sold 150,000 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $45K.
Rivernorth Capital Management first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 9 quarters.
Rivernorth Capital Management's Deep Medicine Acquisition Corp. Rights position peaked at $52.5K in Q3 2023.
0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on Rivernorth Capital Management's 13F filing for Q1 2024, filed 15 May 2024.